+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2024 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
From
Global CD19 Antibody Market & Clinical Pipeline Outlook 2028 - Product Thumbnail Image

Global CD19 Antibody Market & Clinical Pipeline Outlook 2028

  • Report
  • October 2023
  • 420 Pages
  • Global
From
From
From
Thematic Intelligence - Biosimilars in oncology - Product Thumbnail Image

Thematic Intelligence - Biosimilars in oncology

  • Report
  • December 2023
  • 76 Pages
  • Global
From
From
Peptide Therapeutics Market 2024-2028 - Product Thumbnail Image

Peptide Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 148 Pages
  • Global
From
Protein Therapeutics Market 2024-2028 - Product Thumbnail Image

Protein Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 191 Pages
  • Global
From
From
From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
From
Loading Indicator